Chemotherapy and radiotherapy are common modalities for cancer treatment. While targeting rapidly growing cancer cells, they also damage normal tissues and cause adverse effects. From the initial insult such as DNA double-strand break, production of reactive oxygen species (ROS) and a general stress response, there are complex regulatory mechanisms that control the actual tissue damage process. Besides apoptosis, a range of outcomes for the damaged cells are possible including cell cycle arrest, senescence, mitotic catastrophe, and inflammatory responses and fibrosis at the tissue level. Feather and hair are among the most actively proliferating (mini-)organs and are highly susceptible to both chemotherapy and radiotherapy damage, thus provide excellent, experimentally tractable model systems for dissecting how normal tissues respond to such injuries. Taking a comparative biology approach to investigate this has turned out to be particularly productive. Started in chicken feather and then extended to murine hair follicles, it was revealed that in addition to p53-mediated apoptosis, several other previously overlooked mechanisms are involved.
| INTRODUC TI ON
As one of the most proliferative organs in adult life, hair follicles are highly vulnerable to the damage from both chemotherapy and radiotherapy and hair loss, presented clinically as chemotherapyinduced alopecia (CIA) or radiotherapy-induced alopecia (RIA), is a common adverse effect. [1, 2] This makes hair follicles a widely employed model to dissect the mechanisms underlying the damage responses of rapidly growing tissues to both chemotherapy and radiotherapy. The murine hair follicle has long been a favoured model for exploring the molecular mechanisms of CIA [3] [4] [5] [6] [7] [8] [9] and RIA. [10] [11] [12] [13] Mechanisms learned from the studies in mouse hair follicle [3] [4] [5] [6] [7] [8] [9] [14] [15] [16] [17] have been translated reasonably well to ex vivo studies utilizing human scalp hair follicle organ culture, [18, 19] or most recently, to human scalp skin xenotransplants in immunocompromised mice. [9, 20] tissue level. Feather and hair are among the most actively proliferating (mini-)organs and are highly susceptible to both chemotherapy and radiotherapy damage, thus provide excellent, experimentally tractable model systems for dissecting how normal tissues respond to such injuries. Taking a comparative biology approach to investigate this has turned out to be particularly productive. Started in chicken feather and then extended to murine hair follicles, it was revealed that in addition to p53-mediated apoptosis, several other previously overlooked mechanisms are involved.
Specifically, Shh, Wnt, mTOR, cytokine signalling and ROS-mediated degradation of adherens junctions have been implicated in the damage and/or reparative regeneration process. Moreover, we show here that inflammatory responses, which can be prominent upon histological examination of chemo-or radiotherapy-damaged hair follicle, may not be essential for the hair loss phenotype. These studies point to fundamental, evolutionarily conserved mechanisms in controlling tissue responses in vivo, and suggest novel strategies for the prevention and management of adverse effects that arise from chemo-or radiotherapy.
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| B RE AK ING THE HAIR FOLLI CLE MONOP OLY IN CIA AND RIA RE S E ARCH: ENTER THE FE ATHER FOLLI CLE
Feather and hair are epithelial organs from convergent evolution. Similar to the hair follicles, the feather follicles are formed through reciprocal interactions between the epithelium and mesenchyme. [21] [22] [23] [24] [25] [26] Such epithelial-mesenchymal interactions continue to regulate post-natal follicle function. [21, [27] [28] [29] [30] In their adult life, both form a follicular structure and have a dermal papilla in the proximal end that controls their cyclic growth and regeneration. They even both form a localized niche to store their epithelial stem cells that are critical for their growth cycle ( Figure 1A ,B). [27, 31] At the molecular level, a set of evolutionarily conserved signalling pathways, including FGF, BMP, Wnt, Shh and Notch, are involved in the regulation of their morphogenesis, homeostasis and regeneration. [21, [27] [28] [29] [30] [32] [33] [34] [35] [36] [37] There are unique features of the feather follicle, however, that favour the experimental use of this peculiar epithelial organ. One such feature is the mesenchymal pulp, which provides nutritional support allowing for a much larger follicle structure than hair (compare Figure 1A ,C,D of the feather follicle with Figure 1B ,E,F of the hair follicle). This larger size makes it easier for micro-dissection and direct experimental intervention/manipulation in vivo. [28] [29] [30] [31] In addition, the feather structure is much more complex than that of the hair, which can serve as a visible "archival" morphological record after damaging insult ( Figure 1G ). This then becomes the Rosetta stone for deciphering the underlying molecular mechanisms and facilitates the exploration of damage responses to chemo-or radiotherapy. By using these complementary skin appendage models, we have begun to unveil how chemotherapy and radiotherapy impact on the damage response pathways embedded in vertebrate tissues.
| CIA : BA S I C CON CEP TS
Conventional chemotherapy drugs, such as cyclophosphamide (CYP), 5-fluorouracil (5-FU), doxorubicin, cisplatin and taxol, exert their cytotoxic effect by perturbing various aspects of cellular physiology including DNA replication, RNA synthesis, metabolism and cellular structures. [38] Some of these drugs induce more severe hair loss while others cause only mild or hardly any hair loss. [1, 2] How they differ in pilotoxicity is not well understood, and even less understood is why the pilotoxicity of the same drug can vary so much among different individuals (from absent, mild to massive alopecia), despite a comparable dose and application regime. [1] [2] [3] The mechanism of CIA has been a topic of intensive investigation (for a systematic review see ref. [3] ). Because the matrix keratinocytes in the hair bulb are highly proliferative, especially below Auber's line of mature anagen VI hair follicles, [39] unsurprisingly, cell cycle-targeting chemotherapy drugs induce extensive cell death in this region. Additionally, the melanocytes of the hair follicle pigmentary unit are also prominently affected, possibly due to their sensitivity to reactive oxygen species (ROS)-associated cytotoxicity. [6] The apoptosis of hair matrix keratinocytes is a p53-driven process in mice, [8] and likely also in human. [18] Recently, it was shown that in addition to activation of apoptosis, chemotherapy also perturbs the terminal differentiation programme in hair follicle keratinocytes, [7] possibly reflecting the disruption of global RNA synthesis. [40] Morphologically, chemotherapy can induce various degree of hair follicle dystrophy and disrupt the continuous growth of the hair shaft. The shedding of dystrophic hair shafts, which can no longer be firmly anchored in the hair canal by the interlocking cuticulae of the hair shaft and the inner root sheath, leads to hair loss. [3] Depending on the severity of injury and the repair/regeneration dynamics, two distinct mechanisms can be observed: in the "dystrophic anagen" pathway, the damaged hair follicles remain in the growth phase of the hair cycle (anagen), which actually becomes abnormally prolonged, yet typically produces brittle and/or dys-pigmented hair shafts; in the "dystrophic catagen" pathway, the hair follicles prematurely enter an apoptosis-driven involution process (catagen), followed by a greatly shortened telogen and then an accelerated construction of new, healthy anagen hair follicles, thus leading to massive initial CIA, but also the most rapid re-growth of normally pigmented hair.
[3-6] F I G U R E 1 Chemotherapy disrupts feather and hair development. A, B, Diagrams showing the feather and hair follicle structures. They both have a dermal papillae (dp) at the proximal end that anchors the structure. The feather follicle has a mesenchymal pulp that supports its growth. The follicle bulge (fb; ref. [31] ) is where the epithelial stem cells locate in the feather follicle. C, BrdU 1-h pulse showing the proliferating feather epithelium (red; detected with a monoclonal antibody from the Hybridoma Bank #G3G4). The growing wing contour feather follicle is about 1-3 mm in diameter. Bar = 200 μm. D, Shh expression in the branched feather epithelium (red; detected with a monoclonal antibody from the Hybridoma Bank #5E1). The non-branched feather rachis (ra) does not express Shh. Bar = 200 μm. E, F, The mouse pelage hair follicle is about 100-200 μm in size, with Ki67+ cells (green) in the hair bulb, and Shh (red) asymmetrically expressed in the matrix keratinocytes. Bar = 50 μm. G, A representative feather disrupted by cyclophosphamide (CYP) chemotherapy. Defects are seen only in the branched feather filament, but not the central rachis. Bar = 1 cm. (adopted from [42] with permission)
| CON S ERVED ROLE OF S HH S I G NALLING IN VERTEB R ATE EPITHELIAL TISSUE DAMAG E BY CHEMOTHER APY
These experimentally well-supported, conventional concepts of CIA pathobiology became greatly enriched when the response of chicken feather follicles to chemotherapy was examined. This approach revealed that, unexpectedly, Shh signalling is also prominently involved in the follicular damage response. [41, 42] Although it is incompletely understood how specifically Shh signalling is involved, and what are the upstream events that inhibit Shh gene expression, the implication of this additional, important pathway represents a major step-forward in CIA pathobiology, not the least since it invites novel CIA intervention strategies that had previously not been considered.
One distinctive feature in feather development is branching morphogenesis, which produces the branched feather filaments. [21, [27] [28] [29] [30] [31] This process is coordinated by complex molecular interactions involving FGF, Notch, Wnt, BMP and Shh signalling [27] [28] [29] [30] [31] -not unlike hair follicle development. [32] [33] [34] [35] [36] [37] The central shaft of the feather (rachis) is not branched. While most molecules do not show distinction in the branched filament or the non-branched rachis, Shh is specifically expressed in the branched region ( Figure 1D ). [30] This peculiar feature elegantly illustrates how chemotherapy damages the feather follicle: in the perturbed feathers, only the branched area showed reduced cell proliferation with concomitant reduction of Shh expression. The rachis region remained unperturbed ( Figure 1G ). [42] These results pinpoint a specific role of Shh signalling in chemotherapyinduced tissue damage, which is further confirmed in the CIA mouse model. [42] Thus, the down-regulation of Shh expression is a conserved feature in chemotherapy-induced epithelial damage. We are currently testing whether this mechanism is also conserved in organcultured human hair follicles. The available preliminary evidence suggests that this may indeed be the case. [43] It remains unclear how chemotherapy drugs down-regulate Shh gene expression. Given the diverse mechanisms of drug function, multiple routes are conceivable. For instance, drugs may induce a DNA damage response, which then activates a wide range of subsequent signalling processes including p53 activation, cell cycle arrest and apoptotic pathways (Figure 2 ). Alternatively or in parallel, these drugs may induce metabolic stress, [44] and promote reprogramming of a wide range of cellular activities via mTOR and AMPK signalling. [45, 46] Furthermore, it is conceivable that a general stress response triggered by chemotherapy drugs, such as the excessive production of ROS, unfolded protein response (ER stress) and ERK/p38/JNK activation, may down-regulate Shh gene expression ( Figure 2 ). In addition, a generalized suppression of intrafollicular RNA synthesis by cell cycle-targeting cytostatic agents [40] may nonspecifically also reduce Shh transcription in an area of the vertebrate epithelium that is particularly vulnerable to reduced Shh signalling activity.
Future investigations along this line, ideally both in feather and hair follicle models, are required to elucidate the upstream events of Shh regulation, and to clarify why some drugs induce hair loss while others do not and why there is so much individual variation in the chemotherapy-response of hair follicles. Through this comparative biology approach, the underlying conserved principles of epithelial damage will be elucidated, and the species-specific responses can be filtered out.
| D IVER S E MECHANIS MS OF HOW I ONIZING R AD IATI ON DAMAG E S THE NORMAL TISSUE
Radiotherapy alone or in combination with chemotherapy is widely employed for the treatment of both primary and metastatic cancers.
Despite technical advances in the methods of ionizing radiation (IR)
delivery and dose fractionation, hair loss from radiotherapy still occurs. [1, 2] Since the 1960s, it has been well known that IR can disrupt hair growth and lead to hair loss. [10] [11] [12] [13] 47] IR injury can even lead to permanent scarring alopecia or loss of hair pigmentation. [1, 2] This suggests an irreversible loss of hair follicle stem cells and melanocyte stem cells, which appear to be relatively resistant to most, but not all, chemotherapeutic agents. [3] Apoptosis is induced in the murine hair matrix within 6 hours after IR irradiation, even at a relatively low dose of 2 Gy. [13] Immediately following IR injury, mTOR signalling is activated in the hair bulb, which helps to restrict apoptosis and enhance regenerative proliferation. [48] Furthermore, IR suppresses Wnt signalling in the hair follicle in a p53-dependent manner. Reactivation of Wnt signalling is required for successful repairing of the hair follicle. [13] Augmentation of Wnt signalling by local supplementation of Wnt3a protein is able to reduce hair loss from both radiotherapy and chemotherapy. Accelerated mobilization of multipotent progenitor cells in the lower proximal cup and/or the outer root sheath has been documented, which then regenerate the germinative cells and the internal hair bulb structures. [13] Generally, mammalian skin is much more radio-resistant than its appendages. Only after a higher dose of 40 Gy irradiation, a significant damage to the murine skin epidermis is induced in a process termed "radiation dermatitis." [49, 50] For IR-induced epidermal damage, a recently revealed key event is the disruption of adherens junctions, which then leads to loss of cell-cell contact between epidermal keratinocytes. In rodent epidermis, this disruption of cell adhesion is mediated by ROS-activated Src/Abl kinases and subsequent degradation of the E-cadherin/β-catenin complex; activation of Wnt and Hippo signalling are then followed to drive skin regeneration. [49] Interestingly, the epidermal keratinocytes do not undergo apoptosis even after 40 Gy IR irradiation; rather, they enter a mitotic catastrophe programme and are replaced by clonal expansion from residual epidermal stem cells. [47, [49] [50] [51] Another strikingly different scenario has been documented in feather follicles after IR irradiated. [52] 5 Gy irradiation induces no significant damage to the feather follicle. After 10 Gy irradiation, still no apoptosis is induced; however, IR-induced cytokine responses cause a marked patterning defect in feather development, that is, the regular feather branching is disrupted ( Figure 3 ). Since exogenous cytokines recapitulate the branching defect, whereas blocking the cytokine signalling partially rescues IR-induced tissue damage, [52] this suggests that a cytokine-induced patterning mechanism controls the IR damage in the feather follicle. Significant cell death is only seen after 20 Gy irradiation, which induces widespread apoptosis both in the epithelium and mesenchyme of the feather follicle. [52] Thus, the feather and hair follicles respond to IR injury in dramatically different manner.
Mechanistically, IR is known to damage the genomic DNA and at the same time induces high level of ROS, together with other early immediate responses (reviewed in [53, 54] ). Different cell and tissue types show distinct sensitivity to IR damage. For instance in mouse skin, the hair follicles show extensive apoptosis after 5 Gy irradiation, whereas the epidermis is only damaged after 40 Gy irradiation. [13, [48] [49] [50] [51] The fate choices of irradiated cells are complex: cells may resist [55] or undergo apoptosis, [13] senescence, [56] differentiation [57] or mitotic catastrophe, [51] depending on rules that are not fully understood (Figure 4) . [58] [59] [60] It is therefore of critical importance to decipher the regulatory mechanisms underlying these diversified cell fate choices in radiation biology. Furthermore, IRinduced hair follicle damage is under chronobiological control, that is, the peripheral and possibly also central clock activity. [61, 62] This is not surprising, because the cycling and pigmentation of both murine and human hair follicles are regulated by the peripheral clock.
[ [63] [64] [65] When irradiated in the morning while the hair matrix cells are more proliferative, more damage is induced, whereas less damage is induced when irradiated in the afternoon. [61] Thus, an additional layer of complexity is imposed on the regulation of RIA.
Taken together, the exploration of radiation biology using avian feather and mammalian hair/skin models highlights the complexity of vertebrate tissue responses to IR damage. It is intriguing to consider whether the IR response is less conserved and may have undergone major evolutionary changes between avian and mammalian systems, and why this may be so.
| PYROP TOS IS MAY NOT B E E SS ENTIAL FOR CHEMOTHER APY OR R AD I OTHER APY-INDUCED HAIR DAMAG E
Cytokine production and inflammatory responses are often induced in the target and non-target tissues by chemotherapy and/or radiotherapy, with tissue damage possibly being induced as a secondary response to inflammation. [66, 67] Pyroptosis is a recently identified, novel form of cell death that is supposed to be a key mechanism in F I G U R E 3 Ionizing radiation (IR) damages the feather follicle. A, Gross morphology of IR-damaged feathers. All feathers after 5 Gy, and 90% feathers after 10 Gy irradiation were normal. After 20 Gy irradiation, a spectrum of defects was induced from disrupted branches to breaking down of the whole feather. B, Histology and whole-mount analysis of IR-induced damage in the feather follicle. After 5 Gy irradiation, the feathers developed normally. After 10 Gy irradiation, a patterning defect was noticed in the majority of feather follicles (87.5%). Significant cell loss was observed only after 20 Gy irradiation. C, Exogenous cytokines disrupted the regular feather branching. Bar = 1 cm in A, 100 μm in B-C. Adopted from Ref. [52] F I G U R E 4 Ionizing radiation (IR) induces complex, contextdependent cell fate choices. Cells may repair or retain the damage via reduced p53 activation and increased Bcl2 expression to promote survival. [55] Foxo4 expression may block p53 activation and induce senescence [56] IR induces melanocyte stem cell differentiation in their niche via ATM/ATR-dependent and p53/p16/p19-independent mechanisms. [57] IR may induce cell apoptosis, depending on the expression level of IAP proteins and the activation status of EGFR signalling. Mitotic catastrophe is another possible outcome after IR stress, particularly in epidermal keratinocytes [51] inflammatory tissue damage. [68] In pyroptosis, the cell bursts after Gasdermin proteins forming small pores in the plasma membrane. [68] By using the GasderminE−/− mice, it was shown that cisplatin-induced gastrointestinal side effects are mediated by this type of inflammatory response, and pyroptosis plays a critical role. [68] To examine whether pyroptosis is involved in CIA or RIA, we tested CYP-induced hair loss and IR-induced hair loss using the GasderminE−/− mice, under the same treatment protocol that are standard in the literature. [4, 13] Our preliminary data showed that the hair loss responses in GasderminE−/− mice are similar to wild-type mice ( Figure 5) . Thus it appears that, in contrast to the gastrointestinal system, pyroptosis may not be essential for chemotherapy or radiotherapy-induced hair loss in mice, neither in the initial destruction nor in the recovery and regeneration of the hair follicle. However, since inflammatory responses are critical for radiation dermatitis, it remains to be tested whether pyroptosis and GasderminE are involved in this type of radiation damage.
| CON CLUS IONS
As representative of actively growing vertebrate (mini-)organs, hair and feather follicles provide attractive, accessible and instructive models for dissecting how chemotherapy and radiotherapy damage healthy tissues. As such, the distinct growth modes of these two vertebrate skin appendages offer tremendous possibilities to examine a wide range of molecular pathways that are involved in their damage and repair responses. Such a comparative biology approach will not only help to elucidate fundamental, evolutionarily conserved mechanisms that control vertebrate tissue responses to chemoand/or radiotherapy in vivo, but also suggest novel strategies for the prevention and management of the associated adverse effects.
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